Skip to main content

Market Overview

Demand For Packaged Food Drops In US: Has 'Miracle' Drug Ozempic Got Something To Do With It?

Share:
Demand For Packaged Food Drops In US: Has 'Miracle' Drug Ozempic Got Something To Do With It?

As the cost of living in the U.S. keeps soaring, Americans seem to be shunning comfort food, despite the necessity to eat. Notably, packaged-food manufacturers are witnessing a significant drop in their product sales. This shift in consumer behavior is sparking curiosity and concern among industry watchers.

According to a report from Barron’s, TD Cowen analyst Robert Moskow detailed three primary factors behind the declining sales volumes of packaged-food makers. Moskow warned that this downturn could persist in 2024 unless firms take substantial measures to reduce prices.

First up, the high prices of food products have led consumers to economize their shopping habits. Moskow noted that consumers are “wasting less, resisting impulse purchases, and trading down to cheaper options.”

This trend is seemingly backed by the 1.8% drop in grocery store volumes over the past 52 weeks.

See Also: Walmart Reports ‘Slight Pullback’ In Food Demand As ‘Miracle’ Weight-Loss Drug Ozempic Gains Popularity

Big packaged-food companies, including Conagra Brands (NYSE:CAG), General Mills (NYSE:GIS), Kellanova (NYSE:K), and Kraft Heinz (NASDAQ:KHC), have experienced an even greater decline. Their volumes have fallen 6% or more in the 52-week period ended September 2023.

Moskow attributes 40% of the volume loss to consumers shifting to fresh produce, meat, deli, and bakery products. The remaining 10% is due to market share lost to private label and emerging brands, which have seen increased sales as consumers seek less expensive options.

However, he doesn't see evidence that increased use of drugs like Ozempic for diabetes management and ‘miracle’ weight reduction is behind volume declines, even though it holds the potential to do so in the future.

Should cooler weather, holiday shopping, and improved merchandising fail to boost sales, Moskow believes that these firms will need to make substantial price investments to reverse the trend.

Read Next: Experts Weigh In On Ozempic’s Evolving Side Effects And How To Handle Them

Photo via Shutterstock


Engineered by
Benzinga Neuro, Edited by


Pooja Rajkumari


The GPT-4-based Benzinga Neuro content generation system exploits the
extensive Benzinga Ecosystem, including native data, APIs, and more to
create comprehensive and timely stories for you.
Learn more.


 

Related Articles (GIS + KHC)

View Comments and Join the Discussion!

Posted-In: Ozempic packaged foodNews Economics Media General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com